VDVidal Delgado-Rizo

Vidal Delgado-Rizo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vidal Delgado-Rizo has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prebiotic and Immunologic Effects of Fructans from Agave Tequilana Weber

    by Amelia Minjarez-Ibañez, Jorge Segura-Ortega, Vidal Delgado-Rizo, Luis Jave-Suarez, Luz Gonzalez-Hernandez, Mary Fafutis


  • S.128. Inhibitors of MAPK Pathway ERK1/2 or p38α/p38β Downregulate the Expression of SRP72 Autoantigen in Jurkat Cells Stimulated by IL-1β

    by Victor Arana-Argaez, Erika A Martínez-García, Beatriz Martin-Marquez, José Muñoz-Valle, Oscar Medina-Contreras, Vidal Delgado-Rizo, Minoru Satoh, Mónica Vázquez-Del Mercado

  • T.40. Abnormalities in Intracellular Processing and Expression of Interferon-γ Receptor in Adherent Cells from Leprosy Patients

    by Celia Guerrero-Velazquez, Rocio Lopez-Roa, Vidal Delgado-Rizo, Cecilia Guillen-Vargas, Margarita Montoya-Buelna, Mary Fafutis-Morris

  • Open Access

    Liver fibrosis secondary to bile duct injury: correlation of Smad7 with TGF-β and extracellular matrix proteins

    by María del Pilar Alatorre-Carranza, Alejandra Miranda-Díaz, Irinea Yañez-Sánchez, Oscar Pizano-Martínez, José M Hermosillo-Sandoval, Mónica Vázquez-Del Mercado, Sebastián Hernández-Hoyos, Ricardo Martínez-Abundis, Mary Fafutis-Morris, Jorge Segura-Ortega, et al.

    Background: Liver fibrosis is the result of continuous liver injury stemming from different etiological factors. Bile duct injury induces an altered expression of TGF-β, which has an important role in liver fibrosis because this cytokine induces the expression of target genes such as collagens, PAI-1, TIMPs, and others that lead to extracellular matrix deposition. Smad7 is the principal inhibitor that regulates the target gene transcription of the TGF-β signaling. The aim of the study was to determine whether Smad7 mRNA expression correlates with the gene expression of TGF-β, Col I, Col III, Col IV, or PAI-1 in liver fibrosis secondary to bile duct injury (BDI). Results: Serum TGF-β concentration was higher in BDI patients (39 296 pg/ml) than in liver donors (9008 pg/ml). Morphometric analysis of liver sections showed 41.85% of tissue contained fibrotic deposits in BDI patients. mRNA expression of Smad7, Col I, and PAI-1 was also significantly higher (P < 0.05) in patients with BDI than in controls. Smad7 mRNA expression correlated significantly with TGF-β concentration, Col I and Col III expression, and the amount of fibrosis. Conclusion: We found augmented serum concentration of TGF-β and an increase in the percentage of fibrotic tissue in the liver of BDI patients. Contrary to expected results, the 6-fold increase in Smad7 expression did not inhibit the expression of TGF-β, collagens, and PAI-1. We also observed greater expression of Col I and Col III mRNA in BDI patients and significant correlations between their expression and TGF-β concentration and Smad7 mRNA expression.


  • Open Access

    Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

    by Naela A Arreygue-Garcia, Adrian Daneri-Navarro, Alicia del Toro-Arreola, Angel Cid-Arregui, Oscar Gonzalez-Ramella, Luis F Jave-Suarez, Adriana Aguilar-Lemarroy, Rogelio Troyo-Sanroman, Alejandro Bravo-Cuellar, Vidal Delgado-Rizo, et al.

    Background: Cervical cancer is the second most common cancer in women worldwide. NK and cytotoxic T cells play an important role in the elimination of virus-infected and tumor cells through NKG2D activating receptors, which can promote the lysis of target cells by binding to the major histocompatibility complex class I-related chain A (MICA) proteins. Increased serum levels of MICA have been found in patients with epithelial tumors. The aim of this study was to compare the levels of soluble MICA (sMICA) and NKG2D-expressing NK and T cells in blood samples from patients with cervical cancer or precursor lesions with those from healthy donors. Methods: Peripheral blood with or without heparin was collected to obtain mononuclear cells or sera, respectively. Serum sMICA levels were measured by ELISA and NKG2D-expressing immune cells were analyzed by flow cytometry. Also, a correlation analysis was performed to associate sMICA levels with either NKG2D expression or with the stage of the lesion. Results: Significant amounts of sMICA were detected in sera from nearly all patients. We found a decrease in the number of NKG2D-expressing NK and T cells in both cervical cancer and lesion groups when compared to healthy donors. Pearson analysis showed a negative correlation between sMICA and NKG2D-expressing T cells; however, we did not find a significant correlation when the analysis was applied to sMICA and NKG2D expression on NK cells. Conclusion: Our results show for the first time that high sMICA levels are found in sera from patients with both cervical cancer and precursor lesions when compared with healthy donors. We also observed a diminution in the number of NKG2D-expressing NK and T cells in the patient samples; however, a significant negative correlation between sMICA and NKG2D expression was only seen in T cells.